5-Amino-1MQ

5-Amino-1MQ is a small molecule compound studied for its ability to selectively inhibit nicotinamide N-methyltransferase (NNMT), an enzyme highly expressed in fat tissue. NNMT is involved in regulating cellular NAD+ and SAM levels, both of which play roles in metabolic rate and energy expenditure within fat cells. By targeting NNMT activity, 5-Amino-1MQ is designed to support the body's natural metabolic processes at the cellular level, an approach distinct from appetite-suppression mechanisms used by other metabolic therapies. EdgeRx offers 5-Amino-1MQ through a clinician-supervised oral protocol, prescribed per physician assessment for eligible patients as part of an individualized metabolic health plan.